Evogene Ltd. (EVGN) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Evogene Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.853 -- 00:00:05.719 Welcome to EpoGen's first quarter 2026 results 00:00:05.719 -- 00:00:10.748 conference call. All participants are at present in listen-only mode. 00:00:10.748 -- 00:00:15.576 Following management's formal presentation, we will open the question and answer session. 00:00:15.576 -- 00:00:21.806 You may send questions via chat. Please type your name and company before your question. 00:00:21.806 -- 00:00:26.411 As a reminder, this conference is being recorded May 20, 2026. 00:00:27.301 -- 00:00:32.128 Before we begin, I would like to caution that certain statements made during this earning 00:00:32.128 -- 00:00:37.215 conference call by Avergent's management will constitute forward-looking statements 00:00:37.215 -- 00:00:42.582 that relate to future events. This presentation contains forward-looking statements 00:00:42.582 -- 00:00:47.669 relating to future events, and Avergent LTD, the company, may from time to time 00:00:47.669 -- 00:00:53.136 make other statements regarding our outlook or expectations for future financial 00:00:53.136 -- 00:00:58.148 or operating results and or other matters regarding or affecting us 00:00:58.148 -- 00:01:02.133 that are considered forward-looking statements, as defined in the U.S. 00:01:02.133 -- 00:01:08.400 Private Securities Litigation Reform Act of 1995, the PSLRA, 00:01:08.400 -- 00:01:11.984 and other security laws as amended. 00:01:11.984 -- 00:01:17.090 Statements that are not statements of historical fact may be deemed to be forward-looking 00:01:17.090 -- 00:01:22.497 statements. Such forward-looking statements may be identified by the use of such words 00:01:22.497 -- 00:01:28.046 as believe, expect, anticipate, should, planned, estimated, intent, 00:01:28.046 -- 00:01:33.155 and poten...